Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
801–820 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
GYROGyrodyne, LLC$10.91M—$2.8M—-$3.11M$3.77M$10.71MAI pending
AMODAlpha Modus Holdings, Inc.$10.92M—$7.14K—-$8.02M$2M$0AI pending
VTGNVistagen Therapeutics, Inc.$10.95M—$1.27M+161.1%-$69.69M$16.99M$783KAI pending
SKTGSkytech Orion Global Corp.$10.98M—$12K-92.0%-$8.64M$3K$725KAI pending
QNMEQuanome Technologies, Inc.$11.02M—$17.79M-2.9%-$5.25M$1.3M$203.43KAI pending
XERIXeriant, Inc.$11.02M—$79.67K-87.4%-$838.38K$24.56K$4.22KAI pending
XBIOXenetic Biosciences, Inc.$11.04M—$2.98M+19.0%-$2.68M$6.47M$0AI pending
UPLDUpland Software, Inc.$11.05M—$216.88M-21.1%-$38.9M$31.04M$2.42MAI pending
HUDIHuadi International Group Co., Ltd.$11.05M—$62.9M-15.3%-$1.4M$6.48M$12.19MAI pending
MDCXMedicus Pharma Ltd.$11.07M————$15.17M$137.33KFair valued
ASFHAsiafin Holdings Corp.$11.14M12.7×$5.13M+51.6%-$85.33K$880.46K$624.41KAI pending
NVNINvni Group Ltd$11.17M—R$193.28M+14.4%-R$78.21MR$16.4MR$24.24MAI pending
BIAFbioAffinity Technologies, Inc.$11.26M—$6.16M-34.2%-$14.91M$2.43M$1.38MAI pending
OXBROXBRIDGE RE HOLDINGS Ltd$11.31M88.0×$2.58M+372.0%-$2.08M$4.11M$180KAI pending
MGTIMgt Capital Investments, Inc.$11.32M—$87K-73.0%-$219K$232K$20KAI pending
NIMUNon Invasive Monitoring Systems Inc$11.36M—$6K-73.9%-$488K$160K$2.13MAI pending
EDUCEducational Development Corp$11.42M5.8×$22.91M-33.0%$2.33M$1.66M$6.74MAI pending
KPRXKiora Pharmaceuticals Inc$11.44M—$0-100.0%-$10.84M$7.08M$333.02KAI pending
APHPAmerican Picture House Corp$11.47M23.8×$853.02K+1,519.3%-$534.44K$22.34K—AI pending
IOTRiOThree Ltd$11.48M—$14.71M+40.4%-$1.16M$2.12M$1.58MAI pending